← Evidence map

ReviewJournal of medicinal chemistry2026

Discovery and Development of Voxvoganan: First-in-Class Synthetic Antimicrobial Peptidomimetic.

Wenche Stensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42003840